Eckhardt Sue Gail - Insider Non-Derivative Transactions at Syros Pharmaceuticals, Inc. (SYRS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 5, 2024, Eckhardt Sue Gail's relationship to Syros Pharmaceuticals, Inc. (SYRS) is Director, and currently has 16,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SYRS insiders.
Data Source: SEC.
Eckhardt Sue Gail - Insider Non-Derivative Transactions of SYRS Common Stock
Eckhardt Sue Gail - Insider Non-Derivative Transactions at SYRS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 6, 2024 | Acquisition -- (Common Stock) | 4000 | 0 | 16000 |
| Jun 2, 2023 | Acquisition -- (Common Stock) | 4000 | 0 | 12000 |